Safety and immunogenicity of live attenuated human–bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants

This publication has 20 references indexed in Scilit:

• Review Of Rotavirus Vaccine Trials In Finland
  The Journal of Infectious Diseases, 1996
• Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants
  The Pediatric Infectious Disease Journal, 1995
• Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine
  The Pediatric Infectious Disease Journal, 1994
• Evaluation of a Bovine-Human Rotavims Reassortant Vaccine in Infants
  The Journal of Infectious Diseases, 1993
• Field Trial of Rhesus Rotavirus or Human-Rhesus Rotavirus Reassortant Vaccine of VP7 Serotype 3 or 1 Specificity in Infants
  The Journal of Infectious Diseases, 1992
• Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity
  The Pediatric Infectious Disease Journal, 1992
• Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity
  Vaccine, 1991
• Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infants
  Vaccine, 1990
• Human-Rhesus Reassortant Rotavirus Vaccines: Safety and Immunogenicity in Adults, Infants, and Children
  The Journal of Infectious Diseases, 1988
• Response of adult human volunteers to oral administration of bovine and bovine/human reassortant rotaviruses
  Vaccine, 1986